Case Report
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 26, 2020; 8(12): 2647-2654
Published online Jun 26, 2020. doi: 10.12998/wjcc.v8.i12.2647
Comprehensive treatment of rare multiple endocrine neoplasia type 1: A case report
Chen-Hui Ma, Huai-Bin Guo, Xin-Yan Pan, Wan-Xing Zhang
Chen-Hui Ma, Huai-Bin Guo, Xin-Yan Pan, Wan-Xing Zhang, Department of Hepatobiliary, Hebei General Hospital, Shijiazhuang 050017, Hebei Province, China
Chen-Hui Ma, Graduate School of North China University of Science and Technology, Tangshan 050051, Hebei Province, China
Author contributions: Ma CH and Zhang WX were the patient’s attending physicians, reviewed the literature, and contributed to manuscript drafting and editing; Guo HB and Pan XY collected the record and contributed to manuscript drafting; all authors issued final approval for the version to be submitted.
Informed consent statement: Written informed consent was obtained from the patient.
Conflict-of-interest statement: We declare that we have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Wan-Xing Zhang, MD, Chief Doctor, Professor, Department of Hepatobiliary, Hebei General Hospital, No. 348, Heping West Road, Xinhua District, Shijiazhuang 050017, Hebei Province, China. zhangwx12@hotmail.com
Received: January 14, 2020
Peer-review started: January 14, 2020
First decision: April 8, 2020
Revised: April 25, 2020
Accepted: May 29, 2020
Article in press: May 29, 2020
Published online: June 26, 2020
Processing time: 162 Days and 2.1 Hours
Core Tip

Core tip: Genetic screening is recommended in patients with a family history of multiple endocrine neoplasia type 1 who present with primary hyperparathyroidism and pituitary tumors or gastrointestinal neuroendocrine tumors.